Endo Pharmaceuticals Up on ‘Buy’ Rating (AP via Yahoo! Finance)
Endo Pharmaceuticals Inc. stock gained Friday after a Roth Capital Partners analyst initiated coverage with a “Buy” rating, saying the company’s pain drugs make it the “best in class” and that the shares could rise as much as 22 percent in the next year.
Original post by Yahoo! News Search Results for shingles